Oxford pubs serve the most expensive pints outside of London

first_imgA pint costs more in Oxford pubs than anywhere else in the UK other than London, according to a new study.The average cost across Oxford for a pint is £4.57, second only to London’s £5.19.Carlisle was found to serve the cheapest pints, at an average price at £2.35 followed by Chelmsford at £2.60.The study, conducted by MoneyGuru, found that Edinburgh (£4.35), Bristol (£4.32) and Winchester (£4.30) also served some of the most expensive beer in the UK.A MoneyGuru spokesperson said: “Beer prices are a highly contentious issue in the UK with price hikes becoming more and more frequent.“At the end of 2017, the average pint of bitter rose above £3 for the first time in history, while lager now sits at £3.58.”The study also claimed that Dubai is the most expensive city for beer-drinkers in the world, with the average pint there setting them back £9, while at the other end of the scale, a pint costs just £1.17 in Prague.Last January, Oxford researcher Professor Robin Dunbar claimed that there are links between spending time at the pub and happiness.Dunbar said: “[My] study showed that frequenting a local pub can directly affect people’s social network size and how engaged they are with their local community, which in turn can affect how satisfied they feel in life”last_img read more

Vermont to get $500,000 in suit against drug maker

first_imgAttorney General William H Sorrell announced today that Vermont has joined with other states and the federal government and reached an agreement in principle with AstraZeneca Pharmaceuticals LP, to settle allegations it engaged in an off-label marketing campaign that improperly promoted the antipsychotic drug, Seroquel. AstraZeneca will pay the states and the federal government a total of $520 million in damages and penalties to compensate Medicaid and various federal healthcare programs for harm suffered as a result of this conduct. Vermont s federal and state share of the settlement is approximately a half million dollars.Since Vermont s Medicaid program is paid with both state and federal dollars, the Medicaid program will receive a check for approximately $200,000 after the federal share is deducted. Attorney General William Sorrell hailed the settlement as “a significant victory for Vermont and its consumers.” The improper marketing practices in this case were particularly egregious given the fact that the unapproved uses of these powerful medications were often targeted at our most vulnerable citizens.Seroquel is one of a newer generation of antipsychotic medications (called atypical antipsychotics) used to treat certain psychological disorders. From January 1, 2001 through December 31, 2006, AstraZeneca promoted the sale and use of Seroquel for certain uses that the Food and Drug Administration had not approved. The settlement resolves a government investigation into promotional activities undertaken by AstraZeneca that were directed not only to psychiatrists but also to primary care physicians and other health care professionals for unapproved uses in the treatment of medical conditions such as aggression, Alzheimer s disorder, anger management, anxiety, attention deficit hyperactivity disorder, dementia and sleeplessness.In implementing its marketing campaign, AstraZeneca was also alleged to have made illegal payments to physicians, paying their way to travel to resort locations to advise AstraZeneca about marketing messages for unapproved uses, to serve as authors of articles written by AstraZeneca and its agents, and to conduct studies for unapproved uses of Seroquel. The settlement resolves claims that, as a result of these promotional activities, AstraZeneca caused physicians to prescribe Seroquel for children, adolescents and dementia patients in long term care facilities, which are uses that were not medically accepted indications for which state Medicaid programs would approve reimbursement.As part of the settlement, AstraZeneca will enter into a Corporate Integrity Agreement with the United States Department of Health and Human Services, Office of the Inspector General, which will closely monitor the company s future marketing and sales practices.This settlement is based on qui tam cases that were filed in the United States District Court for the Eastern District of Pennsylvania by relators private parties who filed actions under state and federal false claims statutes.A National Association of Medicaid Fraud Control Units team participated in the investigation and conducted the settlement negotiations with AstraZeneca on behalf of the settling states. Team members included representatives from New York, Massachusetts, Illinois, Ohio, New Jersey, Texas and California.Source: Vermont AG. 5.5.2010last_img read more

Dzeko as the best Player of Roma in the Match against Atlanta

first_imgFootball player of a national representation of Bosnia and Herzegovina Edin Dzeko was elected for the best player of the Roma in the match against Atalanta, which was played on Saturday in the 32nd  round of the Italian Serie A, and ended with the final score 1: 1.Dzeko has scored a goal for Roma, but the fans were unhappy with the result. All in all, after the voting, Edin got the most votes, namely 52 percent.Edin Dzeko, aka Diamond, “swept” the competition, and left Radja Nainggolan behind with 21 percent of the vote, Daniele De Rossi with 18 percent of the vote and Federico Fazio who got 9 percent of the vote.Currently, Roma is on the second place with 72 points, two more than third-placed Napoli, while leading Juventus has 80 points.(Source: klix)last_img read more